- Home
- Advocacy
- Latest News and Practice Data
- Register for LDT Webinar on Nov. 7! Ready Your Laboratory for the FDA’s Stage 1: Adverse Event Reporting Requirement
Under the FDA’s planned regulation, laboratories with LDTs must have a process in place for adverse event reporting starting May 6, 2025. The CAP’s second webinar in our series will discuss existing accreditation requirements and ways laboratories can comply with the FDA rules on medical device-related adverse event reporting. Accreditation experts will review best practices associated with quality management and discuss real world scenarios. Join us on November 7, 2 PM ET/ 1 PM CT, to learn more!
Speakers
- Bobbi S. Pritt, MD, FCAP, chair, Council on Scientific Affairs
- Earle S. Collum, MD, FCAP, chair, Council on Accreditation